IP Verse

Arbutus Biopharma competitive analysis

Latest publications and patents of Arbutus Biopharma New

Explore the latest publications and patents granted to Arbutus Biopharma, showcasing their recent innovations and technological advancements.

Last updated on: Sep 27, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Arbutus Biopharma

EP4241767
Oct 23, 2024Novel Lipids And Compositions For The Delivery Of TherapeuticsGranted And Under Opposition
EP2279254
Jul 5, 2017Novel Lipid Formulations For Nucleic Acid DeliveryGranted And Under Opposition

Latest patents of Arbutus Biopharma opposed by its competitors

Explore Arbutus Biopharma's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 2, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP4241767
Oct 23, 2024Novel Lipids And Compositions For The Delivery Of Therapeutics4
EP2279254
Jul 5, 2017Novel Lipid Formulations For Nucleic Acid Delivery2

Latest PTAB cases involving Arbutus Biopharma

Discover the latest PTAB cases involving Arbutus Biopharma, highlighting their recent legal challenges and patent disputes.

Last updated on: Oct 3, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Arbutus Biopharma

IPR2019-00554Jan 9, 2019MODERNAARBUTUS BIOPHARMAFinal Written Decision
IPR2019-00554Jan 9, 2019MODERNA THERAPEUTICSARBUTUS BIOPHARMAFinal Written Decision
IPR2018-00739Mar 5, 2018MODERNAARBUTUS BIOPHARMAFinal Written Decision
IPR2018-00739Mar 5, 2018MODERNA THERAPEUTICSARBUTUS BIOPHARMAFinal Written Decision
IPR2018-00680Feb 21, 2018MODERNAARBUTUS BIOPHARMAFinal Written Decision
IPR2018-00680Feb 21, 2018MODERNA THERAPEUTICSARBUTUS BIOPHARMAFinal Written Decision

Peer Comparison New

IP litigation analysis comparing Arbutus Biopharma with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 2, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
ARBUTUS BIOPHARMA - 6 - 3Non-Active
ARROWHOUSE5 - - - Highly Aggressive
MODERNA57542Defensive
MODERNA THERAPEUTICS - - 3 - Highly Aggressive